These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 20175287)
1. Differential vasodilation response to olprinone in rabbit renal and common carotid arteries. Minonishi T; Ogawa K; Tokinaga Y; Negoro T; Kimoto Y; Hatano Y J Anesth; 2010 Feb; 24(1):61-6. PubMed ID: 20175287 [TBL] [Abstract][Full Text] [Related]
2. Vasorelaxant effect of olprinone, an inhibitor of phosphodiesterase 3, on mesenteric small artery and vein of rabbits. Fujimoto S; Ohashi M; Hiramoto A; Inoue Y; Nagai K; Shiokawa H; Itoh T Eur J Pharmacol; 1998 Jul; 353(2-3):239-46. PubMed ID: 9726653 [TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms underlying the vasodilatation induced by olprinone, a phosphodiesterase III inhibitor, in rabbit coronary artery. Ohashi M; Dohi Y; Itoh T Br J Pharmacol; 2000 Mar; 129(5):1000-6. PubMed ID: 10696101 [TBL] [Abstract][Full Text] [Related]
4. Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects. Mizushige K; Ueda T; Yukiiri K; Suzuki H Cardiovasc Drug Rev; 2002; 20(3):163-74. PubMed ID: 12397365 [TBL] [Abstract][Full Text] [Related]
5. Vasorelaxant effect of a phosphodiesterase 3 inhibitor, olprinone, on isolated human radial artery. Adachi H; Kamata S; Kodama K; Nagakura T Eur J Pharmacol; 2000 May; 396(1):43-7. PubMed ID: 10822053 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty. Zhao H; Quilley J; Montrose DC; Rajagopalan S; Guan Q; Smith CJ Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2973-81. PubMed ID: 17293498 [TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. Yao M; Roberts DD; Isenberg JS Pharmacol Res; 2011 Jan; 63(1):13-22. PubMed ID: 20971192 [TBL] [Abstract][Full Text] [Related]
8. Involvement of cyclic nucleotides in renal artery smooth muscle relaxation. Karsten AJ; Derouet H; Ziegler M; Eckert RE Urol Res; 2003 Feb; 30(6):367-73. PubMed ID: 12599016 [TBL] [Abstract][Full Text] [Related]
9. Endothelium-independent and endothelium-dependent vasorelaxation by a dichloromethane fraction from Anogeissus Leiocarpus (DC) Guill. Et Perr. (Combretaceae): possible involvement of cyclic nucleotide phosphodiesterase inhibition. Belemnaba L; Ouédraogo S; Auger C; Chataigneau T; Traore A; Guissou IP; Lugnier C; Schini-Kerth VB; Bucher B Afr J Tradit Complement Altern Med; 2013; 10(2):173-9. PubMed ID: 24146440 [TBL] [Abstract][Full Text] [Related]
10. Differential pharmacologic sensitivities of phosphodiesterase-3 inhibitors among human isolated gastroepiploic, internal mammary, and radial arteries. Onomoto M; Tsuneyoshi I; Yonetani A; Suehiro S; Matsumoto K; Sakata R; Kanmura Y Anesth Analg; 2005 Oct; 101(4):950-956. PubMed ID: 16192501 [TBL] [Abstract][Full Text] [Related]
11. Effects of a phosphodiesterase 3 inhibitor, olprinone, on rhythmical change in tension of human gastroepiploic artery. Adachi H; Kakiki M; Kishi Y Eur J Pharmacol; 2005 Dec; 528(1-3):137-43. PubMed ID: 16325808 [TBL] [Abstract][Full Text] [Related]
12. The effects of the phosphodiesterase inhibitor olprinone on global cerebral ischemia. Okayama N; Matsunaga A; Kakihana Y; Fujikawa K; Inoue K; Nagayama T; Takeyama M; Miyata A; Kanmura Y Anesth Analg; 2010 Mar; 110(3):888-94. PubMed ID: 20042441 [TBL] [Abstract][Full Text] [Related]
13. Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP. Mizutani A; Murakami K; Okajima K; Kira S; Mizutani S; Kudo K; Takatani J; Goto K; Hattori S; Noguchi T Shock; 2005 Sep; 24(3):281-7. PubMed ID: 16135969 [TBL] [Abstract][Full Text] [Related]
14. The effects of olprinone, a phosphodiesterase 3 inhibitor, on systemic and cerebral circulation. Ueda T; Mizushige K Curr Vasc Pharmacol; 2006 Jan; 4(1):1-7. PubMed ID: 16472171 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats. Genovese T; Mazzon E; Paterniti I; Esposito E; Cuzzocrea S Neurosci Lett; 2011 Oct; 503(2):93-9. PubMed ID: 21872644 [TBL] [Abstract][Full Text] [Related]
16. Toborinone and olprinone, phosphodiesterase III inhibitors, inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry. Kageyama K; Mizobe T; Nozuchi S; Hiramatsu N; Nakajima Y; Aoki H J Anesth; 2004; 18(2):107-12. PubMed ID: 15127258 [TBL] [Abstract][Full Text] [Related]
17. Clinically relevant concentrations of olprinone reverse attenuating effect of propofol on isoproterenol-induced cyclic adenosine monophosphate accumulation in cardiomyocytes. Kurokawa H; Matsunaga A; Tanaka H; Hamada H; Kawamoto M; Yuge O Hiroshima J Med Sci; 2008 Mar; 57(1):1-6. PubMed ID: 18578361 [TBL] [Abstract][Full Text] [Related]
18. Effects of a new cardiotonic phosphodiesterase III inhibitor, olprinone, on cardiohemodynamics and plasma hormones in conscious pigs with heart failure. Adachi H; Tanaka H J Cardiovasc Pharmacol; 1997 Jun; 29(6):763-71. PubMed ID: 9234657 [TBL] [Abstract][Full Text] [Related]
19. The enhancement of cellular cAMP with olprinone protects autotransplanted rat kidney against cold ischemia-reperfusion injury. Zhang Y; Ma Q Transplant Proc; 2006 Jun; 38(5):1580-3. PubMed ID: 16797361 [TBL] [Abstract][Full Text] [Related]
20. Role of cyclic nucleotides in regulation of pulmonary artery tone in rabbits. Kapilevich LV; Nosarev AV; Kovalev IV; D'yakova EY; Baskakov MB Bull Exp Biol Med; 2003 Jun; 135(6):610-2. PubMed ID: 12937688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]